Generic Price Fixing Litigation Presses On With 'Overarching Conspiracy' Claims Intact

Judge allows plaintiffs to argue attendance at trade association meetings and job-hopping show scheme to fix drug prices; confidentiality of attorney communication is in dispute.

One 3d render of the word price fixed with two chains - Illustration

Five years after the US government began a probe of the generic drug industry, litigation against more than a dozen companies remains in discovery with no trial date on the horizon. But a recent ruling by the judge overseeing the litigation reveals further details on the claims being made against manufacturers.

In a 15 August opinion, Judge Cynthia Rufe, of the US District Court for the Eastern District of Pennsylvania,...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Generics

More from Biosimilars & Generics